Blood transfusion and the anaesthetist: management of massive haemorrhage

Association of Anaesthetists of Great Britain and Ireland, D Thomas, M Wee, P Clyburn, I Walker, K Brohi, P Collins, H Doughty, J Isaac, P M Mahoney, L Shewry, Association of Anaesthetists of Great Britain and Ireland, D Thomas, M Wee, P Clyburn, I Walker, K Brohi, P Collins, H Doughty, J Isaac, P M Mahoney, L Shewry

Abstract

  1. Hospitals must have a major haemorrhage protocol in place and this should include clinical, laboratory and logistic responses.

  2. Immediate control of obvious bleeding is of paramount importance (pressure, tourniquet, haemostatic dressings).

  3. The major haemorrhage protocol must be mobilised immediately when a massive haemorrhage situation is declared.

  4. A fibrinogen < 1 g.l−1 or a prothrombin time (PT) and activated partial thromboplastin time (aPTT) of > 1.5 times normal represents established haemostatic failure and is predictive of microvascular bleeding. Early infusion of fresh frozen plasma (FFP; 15 ml.kg−1) should be used to prevent this occurring if a senior clinician anticipates a massive haemorrhage.

  5. Established coagulopathy will require more than 15 ml.kg−1 of FFP to correct. The most effective way to achieve fibrinogen replacement rapidly is by giving fibrinogen concentrate or cryoprecipitate if fibrinogen is unavailable.

  6. 1:1:1 red cell:FFP:platelet regimens, as used by the military, are reserved for the most severely traumatised patients.

  7. A minimum target platelet count of 75 × 109.l−1 is appropriate in this clinical situation.

  8. Group-specific blood can be issued without performing an antibody screen because patients will have minimal circulating antibodies. O negative blood should only be used if blood is needed immediately.

  9. In hospitals where the need to treat massive haemorrhage is frequent, the use of locally developed shock packs may be helpful.

  10. Standard venous thromboprophylaxis should be commenced as soon as possible after haemostasis has been secured as patients develop a prothrombotic state following massive haemorrhage.

References

    1. Westerman RW, Davey KL, Porter K. Assessing the potential for major trauma transfusion guidelines in the UK. Emergency Medicine Journal. 2008;25:134–5.
    1. BCSH Guideline. Stainsby D, Maclennan S, Thomas D, Isaac J, Hamilton PJ. Guidelines on the management of massive blood loss. British Journal of Haematology. 2006;135:534–641.
    1. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European Guideline. Critical Care. 2010;14:R52.
    1. Nunez TC, Cotton BA. Transfusion therapy in hemorrhagic shock. Current Opinion in Critical Care. 2009;15:536–41.
    1. Stahel P, Moore EE, Schreier SL, Flierl MA, Kashuk JL. Transfusion strategies in postinjury coagulopathy. Current Opinion in Anesthesiology. 2009;22:289–98.
    1. Diez C, Varon A. Airway management and initial resuscitation of the trauma patient. Current Opinion in Critical Care. 2009;15:542–7.
    1. Dawes R, Rhys Thomas GO. Battlefield resuscitation. Current Opinion in Critical Care. 2009;15:527–35.
    1. Hodgetts T, Mahoney PF, Byers M, Russell MQ. ABC to «C» ABC: redefining the military trauma paradigm. Emergency Medicine Journal. 2006;23:745–6.
    1. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006;46:685–6.
    1. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. Journal Trauma-Injury, Infection and Critical Care. 2008;64:1211–7.
    1. Brohi K, Sing J, Heron M, et al. Acute traumatic coagulopathy. Journal Trauma-Injury, Infection and Critical Care. 2003;54:1127–30.
    1. Wolberg AS, Nieng ZH, Monroe DM, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Journal of Trauma. 2004;56:1221–8.
    1. Hess JR, Lindell AL, Stansbury LG, et al. The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion. 2009;49:34–9.
    1. Sambasivan CN, Schreiber MA. Emerging therapies in traumatic hemorrhage control. Current Opinion in Critical Care. 2009;15:560–8.
    1. Hess JR, Dutton RB, Holcomb JB, et al. Giving plasma at a 1:1 ratio with red cells in resuscitation: who might benefit? Transfusion. 2008;48:1763–5.
    1. Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. American Society of Hematology Education Program. 2007:179–85.
    1. Chowdhury P, Saayman AG, Paulus U, et al. Efficacy of standard dose and 30ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. British Journal of Haematology. 2004;125:69–73.
    1. Johansson PI, Stensbelle J, Rosenburg I, et al. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice. Transfusion. 2007;47:593–8.
    1. Fries D, Krismer A, Klinger A, et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. British Journal of Anaesthesia. 2005;95:172–7.
    1. CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32.
    1. Meng ZH, Wolberg AS, Monroe DM, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. Journal of Trauma. 2003;55:886–91.
    1. Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Critical Care Medicine. 1992;20:1402–5.
    1. National Institute for Health and Clinical Excellence (National Collaborating Centre for Nursing and Supportive Care) Inadvertent perioperative hypothermia. The management of inadvertent perioperative hypothermia in adults. London, UK: National Institute for Health and Clinical Excellence, NICE Clinical Guideline 65; 2008.
    1. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. New England Journal of Medicine. 2006;354:353–65.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir